<DOC>
	<DOCNO>NCT01529255</DOCNO>
	<brief_summary>- The purpose study prove long-term efficacy strategy treatment adjustment W24 accord virological response base ROADMAP concept well standard care strategy . - To evaluate off-treatment durability HBeAg seroconversion patient discontinue treatment due sustain HBeAg seroconversion HBV DNA &lt; 300copies/ml 12 month consolidation treatment</brief_summary>
	<brief_title>EFFORT Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<criteria>Treated telbivudine combine adefovir EFFORT study Patients willing participate extension study Patients provide information consent form Adjustment poor compliance investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Chronic Hepatitis B</keyword>
	<keyword>Compensated Chronic hepatitis B</keyword>
</DOC>